{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:43Z","timestamp":1788307783059,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.vaccine.2010.09.021","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T06:38:37Z","timestamp":1284705517000},"page":"7248-7255","source":"Crossref","is-referenced-by-count":106,"title":["Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009\u2013January 31, 2010"],"prefix":"10.1016","volume":"28","author":[{"given":"Claudia","family":"Vellozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penina","family":"Haber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Guh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthe","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Singleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeStefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.09.021_bib0005","unstructured":"Centers for Disease Control and Prevention (CDC). Use of influenza A (H1N1) 2009 monovalent vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and mortality weekly report (MMWR). Recommendations and reports ed.; 2009. p. 1\u20138."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0010","unstructured":"U.S. Food and Drug Administration. Influenza A (H1N1) 2009. Monovalent. 2010 January 15; 2010 [cited 2010 March 24]. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm181950.htm."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0015","unstructured":"Safety of Influenza A (H1N1) 2009. Monovalent vaccines \u2013 United States, October 1\u2013November 24, 2009. Morbidity and mortality weekly report (MMWR): Centers of Disease Control and Prevention (CDC); 2009. p. 1351\u2013656."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0020","unstructured":"Fiore A, Shay D, Broder K, Iskander J, Uyeki T, Mootrey G, et al. Prevention and control of seasonal influenza with vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and mortality weekly report (MMWR). Recommendations and reports ed: Centers for Disease Control and Prevention (CDC); 2009. p. 1\u201352."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0025","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/j.vaccine.2009.01.125","article-title":"Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring","volume":"27","author":"Vellozzi","year":"2009","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2010.09.021_bib0030","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1001\/jama.296.16.1990","article-title":"Safety of trivalent inactivated influenza vaccine in children 6\u201323 months old","volume":"296","author":"Hambridge","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archpedi.158.11.1031","article-title":"Safety of the trivalent inactivated influenza vaccine among children","volume":"158","author":"France","year":"2004","journal-title":"Arch Pediatric and Adolescent Medicine"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0040","unstructured":"MedImmune. FluMist\u00ae Influenza Vaccine Live, Intranasal; 2009."},{"issue":"21","key":"10.1016\/j.vaccine.2010.09.021_bib0045","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.294.21.2720","article-title":"Adverse events reported following live, cold-adapted, intranasal influenza vaccine","volume":"294","author":"Izurieta","year":"2005","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0050","unstructured":"Centers for Disease Control Prevention F (CDC). Safety of Influenza A (H1N1) 2009 monovalent vaccines \u2013 United States, October 1--November 24. Morbidity and mortality weekly report (MMWR). Centers of Disease Control and Prevention (CDC); 2009. p. 1351\u2013656"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0055","unstructured":"Federal Immunization Task Force. Federal plans to monitor immunization safety for the pandemic 2009 H1N1 influenza vaccination program. In: Indian Health Service et al., editors. U.S. department of health and human services, agency for healthcare research and quality, centers for disease control and prevention, food and drug administration, health resources and services administration; 2009.p. 1\u201320."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0060","unstructured":"Department of health and human services. Vaccine adverse event reporting system. VAERS form. [cited April 8, 2008]. Available from: http:\/\/www.vaers.hhs.gov."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0065","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the vaccine adverse event reporting system","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.021_bib0070","first-page":"10","article-title":"The complicated task of monitoring vaccine safety","volume":"112","author":"Ellenberg","year":"1997","journal-title":"Public Health Rep"},{"issue":"8","key":"10.1016\/j.vaccine.2010.09.021_bib0075","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0080","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4161\/hv.2790","article-title":"Bell's palsy and parenteral inactivated influenza vaccine","volume":"2","author":"Stowe","year":"2006","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0085","unstructured":"American Academy of Neruology (AAN). Reporting toolkit for Guillain\u2013Barr\u00e9 Syndrome; 2009 [cited, Available from: http:\/\/www.aan.com\/go\/practice\/patientsafety\/gbs#update."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0090","unstructured":"Centers for Disease Control and Prevention (CDC). Influenza A (H1N1) 2009 monovalent vaccine safety monitoring: CDC planning recommendations for state, local, tribal, and territorial health officials; 2009 [cited; Available from: http:\/\/www.cdc.gov\/h1n1flu\/vaccination\/safety_planning.htm."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0095","unstructured":"MedDRA MSSO. Medical dictionary for regulartory activities maintenance and support services organization; 2010 [cited; Available from: http:\/\/www.meddramsso.com\/."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0100","unstructured":"Food and Drug Administration. 21 CFR Part 600.80. Postmarketing reporting of adverse experiences: Federal Register; 1997. p. 52252\u201353"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0105","unstructured":"Interim Results: State-Specific Influenza A (H1N1) 2009 monovalent vaccination coverage \u2013 United States, October 2009\u2013January 2010. Morbidity and mortality weekly report (MMWR); 2010. p. 363\u2013638."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0110","unstructured":"Interim Results: State-specific seasonal influenza vaccination coverage \u2013 United States, August 2009\u2013January 2010. Morbidity, morbidity and mortality weekly report (MMWR): US department of health and human services centers for disease control and prevention; 2010. p. 477\u201384."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/2686093","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.021_bib0120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0125","unstructured":"Brighton Collaboration Definitions & Guidelines; 2008 [cited 2010. Available from: http:\/\/brightoncollaboration.org\/public\/what-we-do\/standards\/case-definitions.html."},{"issue":"31","key":"10.1016\/j.vaccine.2010.09.021_bib0130","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0135","series-title":"Harrison's principles of internal medicine","year":"2008"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0140","unstructured":"Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS) \u2013 United States, 1991\u20132001. MMWR; 2003. p. 1\u201324."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0145","first-page":"1","article-title":"Epidemiology of adverse reactions to non-steroidal antiinflammatory drugs","volume":"6","author":"Weber","year":"1984","journal-title":"Advances in Inflammation Research"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0150","first-page":"1","article-title":"Deaths: final data for 2006","volume":"2009","author":"Heron","year":"2006","journal-title":"National Vital Statistics Reports"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1542\/peds.2004-1519","article-title":"Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990\u20132003","volume":"115","author":"McMahon","year":"2005","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2010.09.021_bib0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain\u2013Barr\u00e9 syndrome following vaccination in the national influenza immunization program United States, 1976--1977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0165","series-title":"Immunization safety review. Influenza vaccines and neurological complications","author":"Institute of Medicine (IOM)","year":"2004"},{"issue":"25","key":"10.1016\/j.vaccine.2010.09.021_bib0170","first-page":"1979","article-title":"The Guillain\u2013Barr\u00e9 syndrome and the 1992\u20131993 and 1993\u20131994 influenza vaccines","volume":"339","author":"Lasky","year":"1998","journal-title":"The New Englad Journal of Medicine"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.021_bib0175","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.248.6.698","article-title":"Guillain\u2013Barre syndrome in the United States, 1979\u20131980 and 1980\u20131981 lack of an association with influenza vaccination","volume":"248","author":"Kaplan","year":"1982","journal-title":"JAMA"},{"issue":"26","key":"10.1016\/j.vaccine.2010.09.021_bib0180","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198106253042601","article-title":"Guillain\u2013Barre syndrome and the 1978\u20131979 influenza vaccine","volume":"304","author":"Hurwitz","year":"1981","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0185","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.166.12.1301","article-title":"No association between immunization and Guillain\u2013Barr\u00e9 syndrome in the United Kingdom, 1992\u20132000","volume":"166","author":"Hughes","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0190","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","article-title":"Guillain\u2013Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study","volume":"166","author":"Juurlink","year":"2006","journal-title":"Archives of Internal Medicine"},{"issue":"20","key":"10.1016\/j.vaccine.2010.09.021_bib0195","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/jama.271.20.1602","article-title":"Adverse events associated with childhood vaccines other than pertussis and rubella: summary of a report from the institute of medicine (IOM)","volume":"271","author":"Stratton","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1542\/peds.112.4.815","article-title":"Risk of anaphylaxis after vaccination of children and adolescents","volume":"112","author":"Bohlke","year":"2003","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.vaccine.2010.09.021_bib0205","doi-asserted-by":"crossref","DOI":"10.1542\/peds.107.6.e97","article-title":"Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system","volume":"107","author":"Zanardi","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0210","unstructured":"Update: Guillain\u2013Barr\u00e9 Syndrome among recipients of Menactra\u00ae meningococcal conjugate vaccine \u2013 United States, June 2005\u2013September 2006. Morb mortal wkly rep; 2006. p. 1120\u20134."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0215","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0264-410X(94)90315-8","article-title":"The vaccine adverse event reporting system (VAERS)","volume":"12","author":"Chen","year":"1994","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2010.09.021_bib0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1201.051007","article-title":"Reflections on the 1976 swine flu vaccination program","volume":"12","author":"Sencer","year":"2006","journal-title":"Emerging Infectious Diseases"},{"issue":"5","key":"10.1016\/j.vaccine.2010.09.021_bib0225","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"Vaccine safety datalink Res G the vaccine safety datalink project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.vaccine.2010.09.021_bib0230","unstructured":"U.S. Department of Health and Human Services. National vaccine advisory committee (NVAC); 2010 [cited 2010; Available from: http:\/\/www.hhs.gov\/nvpo\/nvac\/."},{"key":"10.1016\/j.vaccine.2010.09.021_bib0235","unstructured":"U.S. Food and Drug Administration. Influenza virus vaccine for the 2010\u20132011 season; 2010 [cited, Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Post-MarketActivities\/LotReleases\/ucm202750.htm."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10013319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T17:29:26Z","timestamp":1559669366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10013319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":47,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0264410X10013319"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.09.021","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}